BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2021
View Archived Issues
Antidiarrheal drug fights AML
Read More
New phase I study evaluates iExosomes in metastatic pancreatic cancer with KrasG12D mutation
Read More
Oral islatravir studied in new phase III trials as PrEP for HIV
Read More
New CRL4 inhibitors show cytotoxicity tumors with low CUL4 expression
Read More
Copper chelator TDMQ-20 reverses impairments in Alzheimer's disease models
Read More
Positive phase I data support advancing FOR-6219 to phase II development in endometriosis
Read More
Dosing begins in phase I study of DNX-2440 in patients with resectable liver metastasis
Read More
Landos reports positive phase I data for NX-13
Read More
Bi-functionalized nanoparticles described by Vall d'Hebron Institut de Recerca and collaborators
Read More
Eli Lilly presents promising data from SURPASS-2 study of tirzepatide in type 2 diabetes
Read More
University of Virginia patents regulatory T cells armed with bispecific antibodies
Read More
Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology describe mu-opioid agonists
Read More
New JAK-1/TYK2 inhibitors synthesized at the National Institute of Pharmaceutical R&D
Read More
Cough triggers and symptoms among patients treated in COUGH-1 and COUGH-2
Read More
New NTRK1 inhibitors discovered by Luoxin Pharmaceutical, Shandong Luoxin Pharmacy Group
Read More
CYH-33 demonstrates preliminary antitumor activity in PIK3CA-mutant tumors
Read More
[68Ga]NOTA-AE-105 PET/MRI useful for prostate cancer evaluation and reduces biopsy needs
Read More
Youhe reports partial remission in phase I study of YH-001 with teriprizumab in solid tumors
Read More
Apellis ends development of APL-9 for severe COVID-19
Read More
FDA approves Actemra for systemic sclerosis-associated interstitial lung disease
Read More
NIAID closes ACTIV-3 substudies of BRII-196, BRII-198 and VIR-7831
Read More
Novel mutation in the IRF2BPL gene tied to rare neurodevelopmental disorder
Read More
Imperial psychedelic microdosing study pushes the envelope on participant blinding
Read More
TurnSole initiates phase I/II study of TS-020 in hospitalized COVID-19 patients
Read More
NervGen receives FDA feedback on phase I plans with NVG-291
Read More